{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/etf/health-care-select-spdr-xlv/",
 "dataUrl": "https://clearank.com/etf/health-care-select-spdr-xlv/data.json",
 "title": "Health Care SPDR (XLV) ETF Forecast & Price Target (2026)",
 "description": "State Street Health Care Select Sector SPDR (XLV) ETF: 0.08% expense ratio. $43.9B net assets. Health. Fund facts, AI rating, technicals and 2030 projection.",
 "headline": "State Street Health Care Select Sector SPDR ETF (XLV)",
 "published": "2026-06-06T09:16:01+00:00",
 "modified": "2026-09-23T02:40:51.228+00:00",
 "generated": "2026-09-23T08:09:59.404Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "XLV",
  "name": "State Street Health Care Select Sector SPDR ETF",
  "type": "ETF",
  "exchange": "NYSE",
  "currency": "USD",
  "sector": null,
  "industry": null,
  "country": "United States",
  "website": null
 },
 "quote": {
  "price": 169.89,
  "previousClose": 169.01,
  "change": 0.88,
  "changePercent": 0.52,
  "open": 168.78999,
  "high": 170.72,
  "low": 167.87,
  "volume": 7037068,
  "averageVolume": 7837847,
  "marketCap": 28321159168,
  "fiftyTwoWeekHigh": 176.60001,
  "fiftyTwoWeekLow": 133.73,
  "marketOpen": false,
  "asOf": "2026-09-23T02:40:51.000Z"
 },
 "statistics": {
  "pe": 30.19587,
  "eps": null,
  "dividendYield": 0.015114773939100995,
  "beta": null,
  "priceToSales": null,
  "priceToBook": null,
  "revenueTtm": 0,
  "grossMargin": null,
  "returnOnEquity": null
 },
 "technicals": {
  "rsi": 44.08,
  "macd": 0.14,
  "sma50": 167.09,
  "sma200": 156.07,
  "rsiSignal": "Neutral",
  "trend": "Bullish",
  "pricePosition": "Bullish",
  "macdSignal": "Neutral",
  "rating": "Bullish"
 },
 "analysis": {
  "rating": "Buy",
  "score": 75,
  "consensus": "Buy",
  "fairValue": null,
  "analystTarget": 183.48,
  "analystCount": null,
  "wallStreetConsensus": "",
  "generatedAt": "2026-09-23T02:40:51.000Z",
  "priceAtAnalysis": 169.89,
  "volatility": {
   "daily": 1.1,
   "risk": "etf"
  }
 },
 "tradePlan": {
  "bias": "Bullish",
  "conservativeEntry": 166.49,
  "aggressiveEntry": 169.89,
  "stopLoss": 161.5,
  "stopLossPercent": 3,
  "targets": [
   174.82,
   183.14,
   191.47
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 148,
    "base": 183.51,
    "upside90th": 227.55
   },
   {
    "year": 2028,
    "downside10th": 146.24,
    "base": 198.23,
    "upside90th": 268.7
   },
   {
    "year": 2029,
    "downside10th": 147.53,
    "base": 214.13,
    "upside90th": 310.78
   },
   {
    "year": 2030,
    "downside10th": 150.44,
    "base": 231.3,
    "upside90th": 355.62
   },
   {
    "year": 2031,
    "downside10th": 154.46,
    "base": 249.85,
    "upside90th": 404.14
   },
   {
    "year": 2032,
    "downside10th": 159.36,
    "base": 269.88,
    "upside90th": 457.06
   },
   {
    "year": 2033,
    "downside10th": 165.03,
    "base": 291.53,
    "upside90th": 514.99
   },
   {
    "year": 2034,
    "downside10th": 171.39,
    "base": 314.91,
    "upside90th": 578.58
   },
   {
    "year": 2035,
    "downside10th": 178.43,
    "base": 340.16,
    "upside90th": 648.47
   },
   {
    "year": 2036,
    "downside10th": 186.13,
    "base": 367.44,
    "upside90th": 725.36
   }
  ]
 },
 "faqCount": 8,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "XLV Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$168.79",
    "Day Range": "$167.87 to $170.72",
    "Prev Close": "$169.01",
    "Volume": "7.04M",
    "52-Week Range": "$133.73 to $176.60",
    "Market Cap": "$28.32B"
   }
  },
  {
   "id": "mi-fund-facts",
   "title": "XLV Fund Facts",
   "text": [
    "State Street Health Care Select Sector SPDR ETF is a sector-focused exchange-traded fund that provides broad exposure to U.S. health care companies. The fund is designed to track the Health Care Select Sector Index, giving investors access to a diversified mix of large-cap businesses across pharmaceuticals, biotechnology, health care equipment and supplies, health care providers and services, life sciences tools and services, and health care technology.",
    "Fund reference data as of Sep 23, 2026. Expense ratio and net assets are reported by the fund; returns are total returns and can differ from price change."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [
      "Period",
      "XLV",
      "Category"
     ],
     "rows": [
      {
       "label": "YTD",
       "cells": [
        "11.08%",
        "-2.39%"
       ]
      },
      {
       "label": "1 month",
       "cells": [
        "4.89%",
        "1.70%"
       ]
      },
      {
       "label": "3 months",
       "cells": [
        "14.50%",
        "-3.03%"
       ]
      },
      {
       "label": "1 year",
       "cells": [
        "26.22%",
        "21.31%"
       ]
      },
      {
       "label": "3 years",
       "cells": [
        "10.40%",
        "6.58%"
       ]
      },
      {
       "label": "5 years",
       "cells": [
        "6.45%",
        "1.49%"
       ]
      },
      {
       "label": "10 years",
       "cells": [
        "10.73%",
        "8.56%"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "analysis",
   "title": "XLV Analysis",
   "text": [
    "XLV is currently trading above its 50-day simple moving average of $167.09 and its 200-day simple moving average of $156.07. The 20-day exponential moving average is at $168.88, also below the current price. The Relative Strength Index (RSI) stands at 44.08, indicating a neutral momentum. The ETF's price is currently $169.89, suggesting it is consolidating near its recent highs with no strong overbought or oversold signals.",
    "The outlook for XLV remains stable, supported by the defensive nature of the health care sector. Over the next 6-12 months, the ETF is expected to continue benefiting from consistent demand for health care services and products, even amidst broader market fluctuations. Its position above key moving averages suggests a potential for continued sideways movement or a gradual upward trend, contingent on sector-specific developments and overall market sentiment. Key factors to monitor include upcoming earnings reports from major health care companies, any significant legislative or regulatory changes impacting the sector, and the broader macroeconomic environment. A shift towards risk-on sentiment could see funds rotate out of defensive sectors, while increased market uncertainty could drive further inflows into health care ETFs like XLV."
   ],
   "lists": {
    "ProTips": [
     "Consider XLV as a core defensive holding within a diversified portfolio.",
     "Monitor regulatory news impacting the pharmaceutical and healthcare services industries.",
     "Evaluate XLV's performance against its benchmark and category during periods of market stress.",
     "The low expense ratio makes XLV a cost-effective way to gain health care sector exposure."
    ]
   }
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this etf moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.43",
    "Correlation with Nasdaq 100 (QQQ)": "+0.25",
    "Correlation with Bitcoin (BTC)": "-0.08",
    "Correlation with Gold (XAU)": "+0.10"
   }
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "The State Street Health Care Select Sector SPDR ETF (XLV) holds 100% of its assets in stocks, with a significant concentration in the health care sector. The fund's expense ratio is a low 0.08%, costing approximately $8.00 per $10,000 invested. With net assets totaling $43.91 billion, XLV is a substantial ETF. The health care sector is known for its defensive characteristics, often performing relatively well during economic downturns due to consistent demand for its products and services. This stability makes XLV a core holding for investors seeking to mitigate broader market volatility.",
    "Its underlying holdings represent companies within the health care sector. This sector typically demonstrates resilient earnings trends due to the non-discretionary nature of health services and pharmaceuticals. The broad diversification across sub-sectors like biotechnology, medical devices, and managed care helps to smooth out individual company earnings fluctuations. Investors look to the aggregate performance of these health care giants to gauge the sector's overall financial health and its contribution to the broader market.",
    "The primary risk for XLV lies in potential regulatory changes impacting the health care industry, such as drug pricing reforms or changes to healthcare policy, which could affect the profitability of its top holdings. Concentration risk, though mitigated by diversification across sub-sectors, remains a factor as the fund tracks a specific sector index. Macroeconomic shifts, particularly those affecting consumer spending on healthcare services, could also influence the ETF's performance."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Net Assets (Market Cap)",
       "cells": [
        "28.32B"
       ]
      },
      {
       "label": "Expense Ratio",
       "cells": [
        "0.0900%"
       ]
      },
      {
       "label": "Yield",
       "cells": [
        "1.50%"
       ]
      },
      {
       "label": "Day High",
       "cells": [
        "$170.72"
       ]
      },
      {
       "label": "Day Low",
       "cells": [
        "$167.87"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "176.60"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "133.73"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bullish RSI Neutral SMA Cross Bullish Price vs SMA Bullish MACD Neutral Golden Cross in effect with the 50-day SMA ($167.09) above the 200-day SMA ($156.07), price action is firmly bullish above key moving averages."
   ],
   "facts": {
    "RSI": "Neutral",
    "SMA Cross": "Bullish",
    "Price vs SMA": "Bullish",
    "MACD": "Neutral"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "44.08"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "0.14"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "167.09"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "156.07"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "trade-plans",
   "title": "XLV Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Lower risk, wait for pullback",
    "Higher risk, immediate entry",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (44.1) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$174.82",
    "TARGET 2": "$183.14",
    "TARGET 3": "$191.47",
    "STOP LOSS": "$161.50"
   }
  },
  {
   "id": "seasonality",
   "title": "Seasonal Patterns",
   "text": [
    "Historical monthly performance trends",
    "Based on 3 years of historical monthly returns"
   ],
   "facts": {
    "Average Jan return": "+1.16%",
    "Average Feb return": "-0.86%",
    "Average Mar return": "-1.21%",
    "Average Apr return": "+1.23%",
    "Average May return": "+0.44%",
    "Average Jun return": "+2.19%",
    "Average Jul return": "+1.79%",
    "Average Aug return": "+1.71%",
    "Average Sep return": "-1.29%",
    "Average Oct return": "-0.69%",
    "Average Nov return": "+3.88%",
    "Average Dec return": "-0.09%"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "1.10%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in XLV in September 2016 would be worth about $23,238 today, compared with about $35,806 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in XLV today could grow to about $21,628 by 2036 in the base case, with a bull case near $42,696 and a bear case around $10,956. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "XLV ETF Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $231 for XLV by 2030 in the base case, from $170 today (1.4x over 4 years). The downside path ends near $150. These are outcomes of a Monte Carlo simulation run on XLV's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using XLV's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "XLV simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$148",
        "$184",
        "$228"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$146",
        "$198",
        "$269"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$148",
        "$214",
        "$311"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$150",
        "$231",
        "$356"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$154",
        "$250",
        "$404"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$159",
        "$270",
        "$457"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$165",
        "$292",
        "$515"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$171",
        "$315",
        "$579"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$178",
        "$340",
        "$648"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$186",
        "$367",
        "$725"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "SPMO Invesco S&P 500 Momentum ETF NYSE $153.30 +0.76%",
     "url": "https://clearank.com/etf/invesco-sp-500-momentum-spmo/"
    },
    {
     "text": "VWO Vanguard FTSE Emerging Markets ETF NYSE $61.14 +1.88%",
     "url": "https://clearank.com/etf/vwo-etf-analysis/"
    },
    {
     "text": "JEPQ JPMorgan Nasdaq Equity Premium Income ETF NASDAQ $61.01 +1.28%",
     "url": "https://clearank.com/etf/jpmorgan-nasdaq-equity-premium-income-jepq/"
    },
    {
     "text": "GPIQ Goldman Sachs Nasdaq-100 Premium Income ETF NASDAQ $58.34 +0.53%",
     "url": "https://clearank.com/etf/gpiq-etf-analysis/"
    },
    {
     "text": "MAGS Roundhill Magnificent Seven ETF CBOE $72.97 +3.56%",
     "url": "https://clearank.com/etf/mags-roundhill-magnificent-seven/"
    },
    {
     "text": "SCHH Schwab U.S. REIT ETF NYSE $22.93 +0.84%",
     "url": "https://clearank.com/etf/schwab-us-reit-schh/"
    },
    {
     "text": "IAU iShares Gold Trust NYSE $81.67 -0.68%",
     "url": "https://clearank.com/etf/iau-etf-analysis/"
    },
    {
     "text": "VTI Vanguard Total Stock Market ETF NYSE $381.10 +1.51%",
     "url": "https://clearank.com/etf/vanguard-total-market-vti/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Popular Comparisons",
   "links": [
    {
     "text": "MU vs WDC Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/mu-vs-wdc/"
    },
    {
     "text": "SCHD vs VYM Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/schd-vs-vym/"
    },
    {
     "text": "SOL/USD vs ADA/USD Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/sol-vs-ada/"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "What is the expense ratio for the State Street Health Care Select Sector SPDR ETF (XLV)?",
   "answer": "The expense ratio for XLV is 0.08%, which translates to approximately $8.00 per $10,000 invested annually. This low cost is a key feature for long-term investors in this sector-tracking ETF."
  },
  {
   "question": "What sectors does the XLV ETF concentrate its holdings in?",
   "answer": "The XLV ETF is highly concentrated in the health care sector, holding 100% of its assets in stocks within this industry. This includes pharmaceuticals, biotechnology, health care equipment, and health care providers and services."
  },
  {
   "question": "What is the distribution yield for the XLV ETF?",
   "answer": "The XLV ETF has a distribution yield of approximately 1.50%. This yield reflects the income generated from the underlying health care companies and distributed to shareholders."
  },
  {
   "question": "How has XLV performed against its category over the past year?",
   "answer": "Over the past year, XLV has returned 26.22%, outperforming its category return of 21.31%. This indicates strong performance relative to its peers in the health care sector."
  },
  {
   "question": "What is the price prediction for XLV ETF in 2030?",
   "answer": "Based on a Monte Carlo simulation, the base case price projection for XLV in 2030 is $231.30. The simulation also indicates a downside price of $150.44 and an upside price of $355.62. These figures represent statistical outcomes and are not price targets or guarantees."
  },
  {
   "question": "What are the key risks associated with investing in the XLV ETF?",
   "answer": "Key risks include potential regulatory changes affecting the health care industry, such as drug pricing reforms, and concentration risk within the health care sector. Macroeconomic shifts impacting healthcare spending also pose a risk."
  },
  {
   "question": "How does the State Street Health Care Select Sector SPDR ETF (XLV) compare to its benchmark index?",
   "answer": "XLV aims to track the Health Care Select Sector Index. Its performance, such as the 11.08% year-to-date return compared to the category's -2.39%, suggests it closely mirrors the index's movements and provides effective sector exposure."
  },
  {
   "question": "What is the current technical momentum of the XLV ETF?",
   "answer": "The current technical momentum for XLV is neutral, with an RSI at 44.1. The ETF is trading above its key moving averages (50-day SMA at $167.09, 200-day SMA at $156.07), indicating stability rather than strong directional trend."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "SPMO",
    "name": "Invesco S&P 500 Momentum ETF NYSE",
    "price": "$153.30",
    "change": "+0.76%",
    "url": "https://clearank.com/etf/invesco-sp-500-momentum-spmo/"
   },
   {
    "ticker": "VWO",
    "name": "Vanguard FTSE Emerging Markets ETF NYSE",
    "price": "$61.14",
    "change": "+1.88%",
    "url": "https://clearank.com/etf/vwo-etf-analysis/"
   },
   {
    "ticker": "JEPQ",
    "name": "JPMorgan Nasdaq Equity Premium Income ETF NASDAQ",
    "price": "$61.01",
    "change": "+1.28%",
    "url": "https://clearank.com/etf/jpmorgan-nasdaq-equity-premium-income-jepq/"
   },
   {
    "ticker": "GPIQ",
    "name": "Goldman Sachs Nasdaq-100 Premium Income ETF NASDAQ",
    "price": "$58.34",
    "change": "+0.53%",
    "url": "https://clearank.com/etf/gpiq-etf-analysis/"
   },
   {
    "ticker": "MAGS",
    "name": "Roundhill Magnificent Seven ETF CBOE",
    "price": "$72.97",
    "change": "+3.56%",
    "url": "https://clearank.com/etf/mags-roundhill-magnificent-seven/"
   },
   {
    "ticker": "SCHH",
    "name": "Schwab U.S. REIT ETF NYSE",
    "price": "$22.93",
    "change": "+0.84%",
    "url": "https://clearank.com/etf/schwab-us-reit-schh/"
   },
   {
    "ticker": "IAU",
    "name": "iShares Gold Trust NYSE",
    "price": "$81.67",
    "change": "-0.68%",
    "url": "https://clearank.com/etf/iau-etf-analysis/"
   },
   {
    "ticker": "VTI",
    "name": "Vanguard Total Stock Market ETF NYSE",
    "price": "$381.10",
    "change": "+1.51%",
    "url": "https://clearank.com/etf/vanguard-total-market-vti/"
   }
  ],
  "comparisons": [
   {
    "ticker": "MU vs WDC Comparison",
    "name": "",
    "url": "https://clearank.com/compare/mu-vs-wdc/"
   },
   {
    "ticker": "SCHD vs VYM Comparison",
    "name": "",
    "url": "https://clearank.com/compare/schd-vs-vym/"
   },
   {
    "ticker": "SOL/USD vs ADA/USD Comparison",
    "name": "",
    "url": "https://clearank.com/compare/sol-vs-ada/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Healthcare →",
   "url": "https://clearank.com/sector/healthcare/"
  },
  "Newly Tracked": [
   {
    "ticker": "EXC",
    "text": "Exelon Corp",
    "url": "https://clearank.com/stock/exc-stock-analysis/"
   },
   {
    "ticker": "GWW",
    "text": "W.W. Grainger Inc.",
    "url": "https://clearank.com/stock/gww-stock-analysis/"
   },
   {
    "ticker": "CDE",
    "text": "Coeur Mining Inc",
    "url": "https://clearank.com/stock/cde-stock-analysis/"
   },
   {
    "ticker": "CCI",
    "text": "Crown Castle Inc.",
    "url": "https://clearank.com/stock/cci-stock-analysis/"
   },
   {
    "ticker": "AME",
    "text": "AMETEK, Inc.",
    "url": "https://clearank.com/stock/ame-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "INOD",
    "text": "↑ 20.05%",
    "url": "https://clearank.com/stock/inod-stock-analysis/"
   },
   {
    "ticker": "GRT/USD",
    "text": "↑ 19.22%",
    "url": "https://clearank.com/crypto/the-graph-grt/"
   },
   {
    "ticker": "GALA/USD",
    "text": "↑ 19.14%",
    "url": "https://clearank.com/crypto/gala-usd-crypto-analysis/"
   },
   {
    "ticker": "RENDER/USD",
    "text": "↑ 18.94%",
    "url": "https://clearank.com/crypto/render-render-usd/"
   },
   {
    "ticker": "SEI/USD",
    "text": "↑ 17.59%",
    "url": "https://clearank.com/crypto/sei-sei/"
   }
  ],
  "Also in Healthcare": [
   {
    "ticker": "VEEV",
    "text": "Veeva Systems Inc.",
    "url": "https://clearank.com/stock/veev-stock-analysis/"
   },
   {
    "ticker": "VKTX",
    "text": "Viking Therapeutics Inc",
    "url": "https://clearank.com/stock/viking-therapeutics-vktx/"
   },
   {
    "ticker": "VRTX",
    "text": "Vertex Pharmaceuticals",
    "url": "https://clearank.com/stock/vertex-vrtx/"
   },
   {
    "ticker": "WST",
    "text": "West",
    "url": "https://clearank.com/stock/wst-stock-analysis/"
   },
   {
    "ticker": "ZTS",
    "text": "Zoetis Inc.",
    "url": "https://clearank.com/stock/zts-stock-analysis/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "alternateName": "CleaRank Financial AI",
     "url": "https://clearank.com",
     "description": "CleaRank is where retail traders research a trade and practice it before risking money. Its research arm, CleaRank Financial AI, publishes daily analysis, trade plans and 10-year projections for more than 1,000 stocks, ETFs, cryptocurrencies, forex pairs and commodities; each page is built from licensed market data, carries the date it was last updated and is reviewed under CleaRank's published editorial code. The CLEAR™ Score rates online brokers and prop firms on regulation, fees, platform reliability and verified trader experience. The research is free; CleaRank is paid for by subscriptions to its trading workbench (Pro $29 a month, Ultra $59 a month), which combines a live trading simulator, a trade journal that imports from broker history, an AI coach grounded in the trader's own trades, a portfolio generator, visualizer and backtester, a prop-firm challenge auditor and 22 trading calculators and scanners. Some free content contains partner links, which are disclosed and do not affect ratings.",
     "slogan": "Clear data. Honest analysis.",
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "image": {
      "@id": "https://clearank.com/#logo"
     },
     "sameAs": [
      "https://x.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank",
      "https://t.me/clearank"
     ],
     "email": "info@clearank.com",
     "contactPoint": [
      {
       "@type": "ContactPoint",
       "contactType": "customer support",
       "email": "info@clearank.com",
       "url": "https://clearank.com/contact/",
       "availableLanguage": "en"
      }
     ],
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     },
     "knowsAbout": [
      "stock analysis",
      "ETF analysis",
      "cryptocurrency analysis",
      "forex trading",
      "trading simulation",
      "trade journaling",
      "position sizing",
      "risk management",
      "prop firm challenges",
      "online broker regulation"
     ],
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "ethicsPolicy": "https://clearank.com/editorial-code/",
     "ownershipFundingInfo": "https://clearank.com/about-us/",
     "owns": {
      "@id": "https://clearank.com/#app"
     },
     "founder": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/06/xlv.png",
     "url": "https://clearank.com/wp-content/uploads/2026/06/xlv.png",
     "width": "1280",
     "height": "720",
     "caption": "Health Care Select Sector SPDR (XLV) ETF performance and holdings analysis for June 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/etf/health-care-select-spdr-xlv/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/etf/health-care-select-spdr-xlv/",
        "name": "Health Care Select Sector SPDR (XLV) ETF Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/etf/health-care-select-spdr-xlv/#webpage",
     "url": "https://clearank.com/etf/health-care-select-spdr-xlv/",
     "name": "Health Care SPDR (XLV) ETF Forecast & Price Target (2026)",
     "datePublished": "2026-06-06T09:16:01+00:00",
     "dateModified": "2026-09-23T02:40:51+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/06/xlv.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/etf/health-care-select-spdr-xlv/#breadcrumb"
     },
     "reviewedBy": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "Person",
     "@id": "https://clearank.com/writer/shaundavidb/#person",
     "name": "Shaun David",
     "jobTitle": "Co-Founder",
     "url": "https://clearank.com/writer/shaundavidb/",
     "image": "https://clearank.com/media/uploads/2025/01/Shaun-David-Author-Image-.jpeg",
     "sameAs": [
      "https://www.linkedin.com/in/shaun-david-697b5817a/"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     }
    },
    {
     "@type": "Article",
     "@id": "https://clearank.com/etf/health-care-select-spdr-xlv/#richSnippet",
     "headline": "Health Care SPDR (XLV) ETF Forecast & Price Target (2026)",
     "name": "Health Care SPDR (XLV) ETF Forecast & Price Target (2026)",
     "description": "State Street Health Care Select Sector SPDR (XLV) ETF: 0.08% expense ratio. $43.9B net assets. Health. Fund facts, AI rating, technicals and 2030 projection.",
     "datePublished": "2026-06-06T09:16:01+00:00",
     "dateModified": "2026-09-23T02:40:51+00:00",
     "author": {
      "@id": "https://clearank.com/#organization"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "about": {
      "@type": "InvestmentFund",
      "name": "State Street Health Care Select Sector SPDR ETF",
      "identifier": [
       {
        "@type": "PropertyValue",
        "propertyID": "tickerSymbol",
        "value": "XLV"
       },
       {
        "@type": "PropertyValue",
        "propertyID": "exchange",
        "value": "NYSE"
       }
      ],
      "description": "State Street Health Care Select Sector SPDR ETF is a sector-focused exchange-traded fund that provides broad exposure to U.S. health care companies. The fund is designed to track the Health Care Select Sector Index, giving investors access to a diversified mix of large-cap businesses across pharmace",
      "provider": {
       "@type": "Organization",
       "name": "State Street Global Advisors"
      }
     },
     "isPartOf": {
      "@id": "https://clearank.com/etf/health-care-select-spdr-xlv/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/06/xlv.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/etf/health-care-select-spdr-xlv/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "What is the expense ratio for the State Street Health Care Select Sector SPDR ETF (XLV)?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The expense ratio for XLV is 0.08%, which translates to approximately $8.00 per $10,000 invested annually. This low cost is a key feature for long-term investors in this sector-tracking ETF."
     }
    },
    {
     "@type": "Question",
     "name": "What sectors does the XLV ETF concentrate its holdings in?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The XLV ETF is highly concentrated in the health care sector, holding 100% of its assets in stocks within this industry. This includes pharmaceuticals, biotechnology, health care equipment, and health care providers and services."
     }
    },
    {
     "@type": "Question",
     "name": "What is the distribution yield for the XLV ETF?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The XLV ETF has a distribution yield of approximately 1.50%. This yield reflects the income generated from the underlying health care companies and distributed to shareholders."
     }
    },
    {
     "@type": "Question",
     "name": "How has XLV performed against its category over the past year?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Over the past year, XLV has returned 26.22%, outperforming its category return of 21.31%. This indicates strong performance relative to its peers in the health care sector."
     }
    },
    {
     "@type": "Question",
     "name": "What is the price prediction for XLV ETF in 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Based on a Monte Carlo simulation, the base case price projection for XLV in 2030 is $231.30. The simulation also indicates a downside price of $150.44 and an upside price of $355.62. These figures represent statistical outcomes and are not price targets or guarantees."
     }
    },
    {
     "@type": "Question",
     "name": "What are the key risks associated with investing in the XLV ETF?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Key risks include potential regulatory changes affecting the health care industry, such as drug pricing reforms, and concentration risk within the health care sector. Macroeconomic shifts impacting healthcare spending also pose a risk."
     }
    },
    {
     "@type": "Question",
     "name": "How does the State Street Health Care Select Sector SPDR ETF (XLV) compare to its benchmark index?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "XLV aims to track the Health Care Select Sector Index. Its performance, such as the 11.08% year-to-date return compared to the category's -2.39%, suggests it closely mirrors the index's movements and provides effective sector exposure."
     }
    },
    {
     "@type": "Question",
     "name": "What is the current technical momentum of the XLV ETF?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The current technical momentum for XLV is neutral, with an RSI of 44.08. The ETF is trading above its key moving averages (50-day SMA at $167.09, 200-day SMA at $156.07), indicating stability rather than strong directional trend."
     }
    }
   ]
  }
 ]
}